NeoRecormon
Drug timelines are a Plus or Pro feature.
22 regulatory and trial events tracked for NeoRecormon, covering 2007-12-20 to 2026-07-03. Get the full timeline:
Most recent: EMA Authorised: NeoRecormon (epoetin beta) — Roche Registration GmbH